Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-13

FDA Approved: ARGATROBAN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Argatroban submitted by Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Argatroban (argatroban)

Snippet

SUPPL AP for ARGATROBAN (ARGATROBAN)